Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a strategy that has led to a 45% increase in its ...

Shares of Amneal Pharmaceuticals (NASDAQ:AMRX) rose 10% on Monday after J.P. Morgan raised its rating on the stock to overweight from neutral, based on in part on the launch of the drug Crexont.